All In Biotech

Drug Trial Radar · NCT05532696

Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients

A Phase Ib/II, Open-Label, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ABT-101 in Patients With Advanced Solid Tumors and HER2 Exon 20 Insertions Mutated Non- Small Cell Lung Cancer

Last checked: Nov 19, 2026Latest source record: Jun 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

61

Planned (sponsor's estimate)

Start

Sep 27, 2022

Primary completion

Nov 2026

Study completion May 2027

Sponsor

Lead sponsor
Anbogen Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 8, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 1b/2, open-label, multicenter study to determine the recommended phase 2 (RP2D) of ABT-101in solid tumor and to explore antitumor activities of ABT-101 in patients with HER 2 mutated non-small cell lung cancer (NSCLC)

Conditions

  • Advanced Solid Tumor
  • Non Small Cell Lung Cancer
  • HER2 Mutations

Interventions

  • ABT-101Drug

    Patients will receive ABT-101 by oral administration on a 28-day cycle

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine the recommended Phase 2 Dose (RP2D) of ABT-101 in Part 1Time frame: 18 months
  2. Determine antitumor activity based on Objective Response Rate (ORR) in Part 2 in patients with NSCLC with targeted mutationTime frame: 36 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Taichung Veterans General Hospital

    Taichung, Taiwan · Recruiting

  • National Cheng Kung University Hospital

    Tainan, Taiwan · Recruiting

  • National Taiwan University Hospital

    Taipei, Taiwan · Recruiting

  • Taipei Medical Univresity Hospital

    Taipei, Taiwan · Recruiting

  • Chang Gung Memorial Hospital, Linkou

    Taoyuan, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.